Jazz Pharmaceuticals Pre-Paid Expenses 2010-2024 | JAZZ

Jazz Pharmaceuticals pre-paid expenses for the quarter ending December 31, 2024 were $0.177B, a 4.35% decline year-over-year.

  • Jazz Pharmaceuticals pre-paid expenses for 2024 were $0.177B, a 4.35% decline from 2023.
  • Jazz Pharmaceuticals pre-paid expenses for 2023 were $0.185B, a 101.8% increase from 2022.
  • Jazz Pharmaceuticals pre-paid expenses for 2022 were $0.092B, a 30.06% decline from 2021.

Jazz Pharmaceuticals Pre-Paid Expenses 2010-2024 | JAZZ

  • Jazz Pharmaceuticals pre-paid expenses for 2024 were $0.177B, a 4.35% decline from 2023.
  • Jazz Pharmaceuticals pre-paid expenses for 2023 were $0.185B, a 101.8% increase from 2022.
  • Jazz Pharmaceuticals pre-paid expenses for 2022 were $0.092B, a 30.06% decline from 2021.